KMT2A is of particular interest since it was found in the early 1990s to be part of recurrent fusion oncogenes that occur in acute myeloid‐ and lymphoid leukemia (AML/ALL).4, 5, 6, 7. This evidence concerns the gene KMT2A and acute myeloid leukemia.